These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 25733192)
21. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis. Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192 [TBL] [Abstract][Full Text] [Related]
22. Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis. Harris MS; Lichtenstein GR Aliment Pharmacol Ther; 2011 May; 33(9):996-1009. PubMed ID: 21385194 [TBL] [Abstract][Full Text] [Related]
23. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894 [TBL] [Abstract][Full Text] [Related]
24. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM; Greenberg GR Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [TBL] [Abstract][Full Text] [Related]
25. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis. Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277 [TBL] [Abstract][Full Text] [Related]
26. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis. Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770 [TBL] [Abstract][Full Text] [Related]
27. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Sutherland LR; May GR; Shaffer EA Ann Intern Med; 1993 Apr; 118(7):540-9. PubMed ID: 8095128 [TBL] [Abstract][Full Text] [Related]
28. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592 [TBL] [Abstract][Full Text] [Related]
29. [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis]. Kim KH; Kim TN; Jang BI Korean J Gastroenterol; 2007 Dec; 50(6):379-83. PubMed ID: 18159175 [TBL] [Abstract][Full Text] [Related]
31. Mesalazine allergy in a boy with ulcerative colitis: clinical usefulness of mucosal biopsy criteria. Wada S; Kumagai H; Yokoyama K; Ito T; Miyauchi A; Sakamoto S; Imagawa T; Tulyeu J; Tanaka M; Yamagata T Clin J Gastroenterol; 2016 Oct; 9(5):302-5. PubMed ID: 27503129 [TBL] [Abstract][Full Text] [Related]
32. Review article: maintenance of remission in ulcerative colitis. Kamm MA Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():21-4. PubMed ID: 12047255 [TBL] [Abstract][Full Text] [Related]
33. Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis. Eliakim R; Karmeli F; Chorev M; Okon E; Rachmilewitz D Scand J Gastroenterol; 1992 Nov; 27(11):968-72. PubMed ID: 1455196 [TBL] [Abstract][Full Text] [Related]
34. [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates]. Buschhausen L; Kruis W; Aymaz S; Weber M; Krakamp B Med Klin (Munich); 2006 Oct; 101(10):791-5. PubMed ID: 17039321 [TBL] [Abstract][Full Text] [Related]
35. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Kam L; Cohen H; Dooley C; Rubin P; Orchard J Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990 [TBL] [Abstract][Full Text] [Related]
36. Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis. Matthis AL; Zhang B; Denson LA; Yacyshyn BR; Aihara E; Montrose MH Inflamm Bowel Dis; 2016 Aug; 22(8):1793-802. PubMed ID: 27416043 [TBL] [Abstract][Full Text] [Related]
37. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298 [TBL] [Abstract][Full Text] [Related]
38. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA]. Jo Y; Matsumoto T; Iida M Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176 [TBL] [Abstract][Full Text] [Related]
39. [Does 5-ASA prevent development of colon cancer in ulcerative colitis?]. Fallingborg JF Ugeskr Laeger; 2006 May; 168(21):2049-51. PubMed ID: 16768921 [TBL] [Abstract][Full Text] [Related]
40. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)]. Maier K; Fischer C; Klotz U; Heinkel K Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]